Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor?
Pruszczyk
P
P
Department of Hypertension and Angiology, Medical Academy, Warsaw, Poland.
Wocial
B
B
Ignatowska-Switalska
H
H
Feltynowski
T
T
Ellafi
M
M
Januszewicz
A
A
Lapiński
M
M
Zukowska-Grojec
Z
Z
Januszewicz
W
W
D000310:Adrenal Gland Neoplasms / Q000097:blood* / Q000378:metabolism* / Q000601:surgery; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D004837:Epinephrine / Q000097:blood / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009478:Neuropeptide Y / Q000097:blood*; D009638:Norepinephrine / Q000097:blood / Q000652:urine; D010673:Pheochromocytoma / Q000097:blood* / Q000378:metabolism* / Q000601:surgery
D014408:Biomarkers, Tumor; D009478:Neuropeptide Y; D009638:Norepinephrine; D004837:Epinephrine